Algernon Partners with ICP for Market Stability
Company Announcements

Algernon Partners with ICP for Market Stability

Algernon Pharmaceuticals (TSE:AGN) has released an update.

Algernon Pharmaceuticals, a Canadian drug development firm, has announced a partnership with ICP Securities Inc. to provide automated market making services for its shares using the ICP Premium™ algorithm. With an initial three-month term and potential month-to-month renewals, the engagement aims to balance the supply and demand for Algernon’s shares without additional compensation or performance-based factors. Additionally, Algernon has granted 425,000 restricted share units to an employee and a consultant, subject to regulatory approval.

For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskAlgernon Pharmaceuticals Extends Warrant Expiry Date
TipRanks Canadian Auto-Generated NewsdeskAlgernon Pharmaceuticals Secures Funding Through Private Placement
TipRanks Canadian Auto-Generated NewsdeskAlgernon Pharmaceuticals Boosts Private Placement
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App